About Imperial College London

Imperial College London Diabetes Centre (ICLDC), a M42 partner, is a state-of-the-art outpatient facility that specialises in diabetes treatment, research, training and public health awareness. In just over a decade, the Centre has gained international renown for its holistic approach to the treatment of diabetes and related complications that enables patients to receive the full spectrum of care they need in one place. ICLDC was established in 2006 in Abu Dhabi by Mubadala in partnership with the UK’s Imperial College London to address the growing demand for diabetes care in the UAE. The centre now operates four branches across Abu Dhabi, Al Dhafra and Al Ain, touching the lives of more than one million people through patient-centric programmes and public health initiatives.